ARS Investment Partners, LLC - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 67 filers reported holding REDHILL BIOPHARMA LTD in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARS Investment Partners, LLC ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q3 2021$240,000
-61.4%
52,495
-41.9%
0.02%
-61.9%
Q2 2021$621,000
-3.4%
90,333
+2.8%
0.06%
-16.0%
Q1 2021$643,000
+2.4%
87,837
+13.0%
0.08%
-2.6%
Q4 2020$628,000
+4.7%
77,714
+32.5%
0.08%
-18.1%
Q3 2020$600,00058,6640.09%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Ibex Investors LLC 444,301$2,284,0001.33%
683 Capital Management, LLC 999,232$5,136,0000.43%
DAFNA Capital Management LLC 35,000$180,0000.10%
MENORA MIVTACHIM HOLDINGS LTD. 421,000$2,164,0000.08%
Migdal Insurance & Financial Holdings Ltd. 397,324$2,042,0000.05%
Claret Asset Management Corp 42,522$219,0000.05%
Orbimed Advisors 564,900$2,904,0000.04%
Altshuler Shaham Ltd 169,446$251,0000.04%
Virtu Financial LLC 60,787$312,0000.02%
MEITAV INVESTMENT HOUSE LTD 48,000$244,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders